Open | - |
Close | - |
Volume / Avg. | 0 / 33.446K |
Day Range | - - - |
52 Wk Range | 5.100 - 19.570 |
Market Cap | $20.602M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 0.47% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kala Bio (NASDAQ: KALA) through any online brokerage.
Other companies in Kala Bio’s space includes: Galecto (NASDAQ:GLTO), T2 Biosystems (NASDAQ:TTOO), Lumos Pharma (NASDAQ:LUMO), NuCana (NASDAQ:NCNA) and Indaptus Therapeutics (NASDAQ:INDP).
The latest price target for Kala Bio (NASDAQ: KALA) was reported by HC Wainwright & Co. on Friday, November 17, 2023. The analyst firm set a price target for 22.00 expecting KALA to rise to within 12 months (a possible 187.58% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Kala Bio (NASDAQ: KALA) is $7.65 last updated March 14, 2024 at 4:52 PM EDT.
There are no upcoming dividends for Kala Bio.
Kala Bio’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Kala Bio.
Kala Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.